KEYNOTE ADDRESS: Future of Interventional Cardiology

136 Pages·2015·8.95 MB·English

ARCH 2015 Keynote Address:
The Future of
Interventional Cardiology
Martin B. Leon, MD
Columbia University Medical Center
Cardiovascular Research Foundation
New York City
ARCH 2015 Symposium
St. Louis, Missouri; April 10, 2015
Disclosure Statement of Financial Interest
ARCH 2015 Symposium;
St. Louis, Missouri; April 10, 2015

Martin B. Leon, MD
Within the past 12 months, I or my spouse/partner have had a financial
interest/arrangement or affiliation with the organization(s) listed below.
Affiliation / Financial Relationship Company
• Grant / Research Support • Abbott, Boston Scientific, Edwards
Lifescience, Medtronic

• Consulting Fees / Honoraria • Meril Lifescience, Micell,

• Shareholder / Equity • Apica, Claret, Coherex, Elixir, GDS,
Medinol, Mitralign, Valve Medical
The Future of IC
PTCA…
The Beginning
The Father of PTCA!
Andreas Gruentzig
1939 - 1985
His dream was the
catheter-based
percutaneous
treatment of vascular
disease in alert, awake
patients!
Andreas’ Tools
Andreas’ Results
The Saga of Balloon Angioplasty
 Frequent dissections,
recoil and poor
angiographic outcomes
 Acute closure (surgical
backup required)
 Ineffective in calcified
(and other) lesions
 RESTENOSIS!!!
Not Good Enough!
The Future of IC
TCT Provokes
Change!
The 1st TCT - 1988
PURPOSE
•
Explore a new era of
interventional device
therapies - innovation!
•
Re-introduce the live case
demonstration format
- education
•
Apply rigorous methods to
evaluate devices and clinical
outcomes - evidence-based
•
Create an international
network of multi-disciplinary
scientists - GLOBAL!
The “New Device” Era
(1988-1993)
• Laser Angioplasty
• Atherectomy (directional,
rotational, and extraction)

• Stents
(the early days)